Meiling Yan
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- interferon and immune responses
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Inflammasome and immune disorders 6
- Protein Kinase Regulation and GTPase Signaling 3
- Mitochondrial Function and Pathology 3
-
- Atherosclerosis and Cardiovascular Diseases 4
- interferon and immune responses 2
- Co-authors
- Jawahar L. Mehta (4 shared papers)Hongtao Diao (11 shared papers)Xiaoqi Shao (11 shared papers)Chang-Ping Hu (3 shared papers)Jiao Guo (9 shared papers)Xianglu Rong (7 shared papers)Wenyi Wang (3 shared papers)Dongwei Wang (5 shared papers)
- Journals
- Cardiovascular Drugs and Therapy (4 papers)Biomedicine & Pharmacotherapy (3 papers)Journal of Ethnopharmacology (3 papers)Cellular Physiology and Biochemistry (2 papers)International Journal of Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meiling Yan
42 papers receiving 851 citations
Meiling Yan's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 134
- Immunology 176
- Nephrology 55
- Cardiology and Cardiovascular Medicine 134
- Molecular Biology 422
Countries citing papers authored by Meiling Yan
This map shows the geographic impact of Meiling Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Yan more than expected).
Fields of papers citing papers by Meiling Yan
This network shows the impact of papers produced by Meiling Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Yan. The network helps show where Meiling Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice Hit paper breakdown → | 2022 | 175 |
| 2 | 2011 | 64 | |
| 3 | 2018 | 50 | |
| 4 | 2018 | 47 | |
| 5 | 2020 | 35 | |
| 6 | 2011 | 31 | |
| 7 | 2018 | 30 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 27 | |
| 10 | 2020 | 26 | |
| 11 | 2022 | 26 | |
| 12 | 2011 | 25 | |
| 13 | 2011 | 24 | |
| 14 | 2015 | 24 | |
| 15 | 2022 | 20 | |
| 16 | 2023 | 16 | |
| 17 | 2019 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2018 | 12 |
About Meiling Yan
Meiling Yan is a scholar working on Molecular Biology, Immunology, Cancer Research, Cell Biology and Oncology, having authored 42 papers that have together received 859 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), MicroRNA in disease regulation (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Mitochondrial Function and Pathology (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (134 citations), Immunology (176 citations), Nephrology (55 citations), Cardiology and Cardiovascular Medicine (134 citations) and Molecular Biology (422 citations). Meiling Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jawahar L. Mehta, Hongtao Diao, Xiaoqi Shao, Chang-Ping Hu, Jiao Guo, Xianglu Rong, Wenyi Wang, Dongwei Wang, Dong Huang and Weifang Zhang. Their work appears in journals such as Cardiovascular Drugs and Therapy, Biomedicine & Pharmacotherapy, Journal of Ethnopharmacology, Cellular Physiology and Biochemistry and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.